カテゴリー： GlobalInfoResearch, 世界

医薬品開発におけるアウトソーシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Outsourcing in Drug Development Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102944）・商品コード：GIR9102944
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月24日（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：サービス・ソフトウェア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、医薬品開発におけるアウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、臨床試験、新薬申請等、用途別セグメントは、製薬産業、バイオテクノロジー産業、医療機器産業等に区分しました。医薬品開発におけるアウトソーシングの世界市場概観、企業動向、企業別医薬品開発におけるアウトソーシングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・医薬品開発におけるアウトソーシングの市場概観
・医薬品開発におけるアウトソーシングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・医薬品開発におけるアウトソーシングの企業別販売動向、市場シェア、市場集中度、競争動向
・医薬品開発におけるアウトソーシングの世界市場規模
・医薬品開発におけるアウトソーシングの北米市場分析（アメリカ、カナダ、メキシコ等）
・医薬品開発におけるアウトソーシングのアメリカ市場規模推移
・医薬品開発におけるアウトソーシングのカナダ市場規模推移
・医薬品開発におけるアウトソーシングのメキシコ市場規模推移
・医薬品開発におけるアウトソーシングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・医薬品開発におけるアウトソーシングのドイツ市場規模推移
・医薬品開発におけるアウトソーシングのイギリス市場規模推移
・医薬品開発におけるアウトソーシングのロシア市場規模推移
・医薬品開発におけるアウトソーシングのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・医薬品開発におけるアウトソーシングの日本市場規模推移
・医薬品開発におけるアウトソーシングの中国市場規模推移
・医薬品開発におけるアウトソーシングの韓国市場規模推移
・医薬品開発におけるアウトソーシングのインド市場規模推移
・医薬品開発におけるアウトソーシングの東南アジア市場規模推移
・医薬品開発におけるアウトソーシングの南米市場分析（ブラジル、アルゼンチン等）
・医薬品開発におけるアウトソーシングの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・医薬品開発におけるアウトソーシングの種類別分析/販売量、売上、市場シェア（臨床試験、新薬申請）
・医薬品開発におけるアウトソーシングの用途別分析/市場規模（製薬産業、バイオテクノロジー産業、医療機器産業）
・医薬品開発におけるアウトソーシングの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・医薬品開発におけるアウトソーシングの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

For a biopharmaceutical industry in flux, outsourcing services are playing a greater and more diverse role in drug development.

Scope of the Report:
The global Outsourcing in Drug Development market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Outsourcing in Drug Development.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Outsourcing in Drug Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Outsourcing in Drug Development market by product type and applications/end industries.

Market Segment by Companies, this report covers
Charles River Laboratories
Covance
ICON
Parexel
Quintiles Transnational
PPD
PRA Health Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Clinical Trials
New Drug Application

Market Segment by Applications, can be divided into
Pharmaceutical Industries
Biotechnology Industries
Medical Device Industries

【レポートの目次】

Table of Contents

1 Outsourcing in Drug Development Market Overview
1.1 Product Overview and Scope of Outsourcing in Drug Development
1.2 Classification of Outsourcing in Drug Development by Types
1.2.1 Global Outsourcing in Drug Development Revenue Comparison by Types (2019-2024)
1.2.2 Global Outsourcing in Drug Development Revenue Market Share by Types in 2018
1.2.3 Clinical Trials
1.2.4 New Drug Application
1.3 Global Outsourcing in Drug Development Market by Application
1.3.1 Global Outsourcing in Drug Development Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Industries
1.3.4 Medical Device Industries
1.4 Global Outsourcing in Drug Development Market by Regions
1.4.1 Global Outsourcing in Drug Development Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Outsourcing in Drug Development Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Outsourcing in Drug Development Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Outsourcing in Drug Development Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Outsourcing in Drug Development Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Outsourcing in Drug Development Status and Prospect (2014-2024)
1.5 Global Market Size of Outsourcing in Drug Development (2014-2024)
2 Manufacturers Profiles
2.1 Charles River Laboratories
2.1.1 Business Overview
2.1.2 Outsourcing in Drug Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Charles River Laboratories Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.2 Covance
2.2.1 Business Overview
2.2.2 Outsourcing in Drug Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Covance Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.3 ICON
2.3.1 Business Overview
2.3.2 Outsourcing in Drug Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ICON Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.4 Parexel
2.4.1 Business Overview
2.4.2 Outsourcing in Drug Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Parexel Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.5 Quintiles Transnational
2.5.1 Business Overview
2.5.2 Outsourcing in Drug Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Quintiles Transnational Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.6 PPD
2.6.1 Business Overview
2.6.2 Outsourcing in Drug Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PPD Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.7 PRA Health Sciences
2.7.1 Business Overview
2.7.2 Outsourcing in Drug Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PRA Health Sciences Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
3 Global Outsourcing in Drug Development Market Competition, by Players
3.1 Global Outsourcing in Drug Development Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Outsourcing in Drug Development Players Market Share
3.2.2 Top 10 Outsourcing in Drug Development Players Market Share
3.3 Market Competition Trend
4 Global Outsourcing in Drug Development Market Size by Regions
4.1 Global Outsourcing in Drug Development Revenue and Market Share by Regions
4.2 North America Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
4.3 Europe Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
4.5 South America Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
5 North America Outsourcing in Drug Development Revenue by Countries
5.1 North America Outsourcing in Drug Development Revenue by Countries (2014-2019)
5.2 USA Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
5.3 Canada Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
5.4 Mexico Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
6 Europe Outsourcing in Drug Development Revenue by Countries
6.1 Europe Outsourcing in Drug Development Revenue by Countries (2014-2019)
6.2 Germany Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
6.3 UK Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
6.4 France Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
6.5 Russia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
6.6 Italy Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Outsourcing in Drug Development Revenue by Countries
7.1 Asia-Pacific Outsourcing in Drug Development Revenue by Countries (2014-2019)
7.2 China Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
7.3 Japan Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
7.4 Korea Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
7.5 India Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
8 South America Outsourcing in Drug Development Revenue by Countries
8.1 South America Outsourcing in Drug Development Revenue by Countries (2014-2019)
8.2 Brazil Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
8.3 Argentina Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
8.4 Colombia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Outsourcing in Drug Development by Countries
9.1 Middle East and Africa Outsourcing in Drug Development Revenue by Countries (2014-2019)
9.2 Saudi Arabia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
9.3 UAE Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
9.4 Egypt Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
9.5 Nigeria Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
9.6 South Africa Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
10 Global Outsourcing in Drug Development Market Segment by Type
10.1 Global Outsourcing in Drug Development Revenue and Market Share by Type (2014-2019)
10.2 Global Outsourcing in Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Trials Revenue Growth Rate (2014-2024)
10.4 New Drug Application Revenue Growth Rate (2014-2024)
11 Global Outsourcing in Drug Development Market Segment by Application
11.1 Global Outsourcing in Drug Development Revenue Market Share by Application (2014-2019)
11.2 Outsourcing in Drug Development Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Industries Revenue Growth (2014-2019)
11.4 Biotechnology Industries Revenue Growth (2014-2019)
11.5 Medical Device Industries Revenue Growth (2014-2019)
12 Global Outsourcing in Drug Development Market Size Forecast (2019-2024)
12.1 Global Outsourcing in Drug Development Market Size Forecast (2019-2024)
12.2 Global Outsourcing in Drug Development Market Forecast by Regions (2019-2024)
12.3 North America Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
12.4 Europe Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
12.6 South America Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Outsourcing in Drug Development Picture
Table Product Specifications of Outsourcing in Drug Development
Table Global Outsourcing in Drug Development and Revenue (Million USD) Market Split by Product Type
Figure Global Outsourcing in Drug Development Revenue Market Share by Types in 2018
Figure Clinical Trials Picture
Figure New Drug Application Picture
Table Global Outsourcing in Drug Development Revenue (Million USD) by Application (2014-2024)
Figure Outsourcing in Drug Development Revenue Market Share by Applications in 2018
Figure Pharmaceutical Industries Picture
Figure Biotechnology Industries Picture
Figure Medical Device Industries Picture
Table Global Market Outsourcing in Drug Development Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Table Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table Charles River Laboratories Outsourcing in Drug Development Type and Applications
Table Charles River Laboratories Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Covance Basic Information, Manufacturing Base and Competitors
Table Covance Outsourcing in Drug Development Type and Applications
Table Covance Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table ICON Basic Information, Manufacturing Base and Competitors
Table ICON Outsourcing in Drug Development Type and Applications
Table ICON Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Parexel Basic Information, Manufacturing Base and Competitors
Table Parexel Outsourcing in Drug Development Type and Applications
Table Parexel Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Quintiles Transnational Basic Information, Manufacturing Base and Competitors
Table Quintiles Transnational Outsourcing in Drug Development Type and Applications
Table Quintiles Transnational Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table PPD Basic Information, Manufacturing Base and Competitors
Table PPD Outsourcing in Drug Development Type and Applications
Table PPD Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table PRA Health Sciences Basic Information, Manufacturing Base and Competitors
Table PRA Health Sciences Outsourcing in Drug Development Type and Applications
Table PRA Health Sciences Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Global Outsourcing in Drug Development Revenue (Million USD) by Players (2014-2019)
Table Global Outsourcing in Drug Development Revenue Share by Players (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Share by Players in 2017
Figure Global Outsourcing in Drug Development Revenue Share by Players in 2018
Figure Global Top 5 Players Outsourcing in Drug Development Revenue Market Share in 2018
Figure Global Top 10 Players Outsourcing in Drug Development Revenue Market Share in 2018
Figure Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Outsourcing in Drug Development Revenue (Million USD) by Regions (2014-2019)
Table Global Outsourcing in Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Market Share by Regions in 2018
Figure North America Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Europe Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure South America Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table North America Outsourcing in Drug Development Revenue by Countries (2014-2019)
Table North America Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Outsourcing in Drug Development Revenue Market Share by Countries in 2018
Figure USA Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Canada Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Mexico Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table Europe Outsourcing in Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Europe Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure Europe Outsourcing in Drug Development Revenue Market Share by Countries in 2018
Figure Germany Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure UK Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure France Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Russia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Italy Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Outsourcing in Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Outsourcing in Drug Development Revenue Market Share by Countries in 2018
Figure China Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Japan Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Korea Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure India Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table South America Outsourcing in Drug Development Revenue by Countries (2014-2019)
Table South America Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Outsourcing in Drug Development Revenue Market Share by Countries in 2018
Figure Brazil Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Argentina Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Colombia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Outsourcing in Drug Development Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries in 2018
Figure Saudi Arabia Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure UAE Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Egypt Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure Nigeria Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Figure South Africa Outsourcing in Drug Development Revenue and Growth Rate (2014-2019)
Table Global Outsourcing in Drug Development Revenue (Million USD) by Type (2014-2019)
Table Global Outsourcing in Drug Development Revenue Share by Type (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Share by Type (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Share by Type in 2019
Table Global Outsourcing in Drug Development Revenue Forecast by Type (2019-2024)
Figure Global Outsourcing in Drug Development Market Share Forecast by Type (2019-2024)
Figure Global Clinical Trials Revenue Growth Rate (2014-2019)
Figure Global New Drug Application Revenue Growth Rate (2014-2019)
Table Global Outsourcing in Drug Development Revenue by Application (2014-2019)
Table Global Outsourcing in Drug Development Revenue Share by Application (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Share by Application (2014-2019)
Figure Global Outsourcing in Drug Development Revenue Share by Application in 2019
Table Global Outsourcing in Drug Development Revenue Forecast by Application (2019-2024)
Figure Global Outsourcing in Drug Development Market Share Forecast by Application (2019-2024)
Figure Global Pharmaceutical Industries Revenue Growth Rate (2014-2019)
Figure Global Biotechnology Industries Revenue Growth Rate (2014-2019)
Figure Global Medical Device Industries Revenue Growth Rate (2014-2019)
Figure Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Outsourcing in Drug Development Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Outsourcing in Drug Development Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
Figure Europe Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
Figure South America Outsourcing in Drug Development Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Outsourcing in Drug Development Revenue Market Forecast (2019-2024)


【掲載企業】

Charles River Laboratories、Covance、ICON、Parexel、Quintiles Transnational、PPD、PRA Health Sciences、

★調査レポート[医薬品開発におけるアウトソーシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102944)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品開発におけるアウトソーシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 創薬におけるアウトソーシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102933 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、創薬におけるアウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、小分子、大分子等、用途別セグメントは、病院と診療所、医療研究所、その他等に区分しました。創薬におけるアウトソーシングの世界市場概観、企業動向、企業別創薬におけるアウトソーシングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・創薬におけるアウトソーシングの市場概観 ・創薬におけるアウトソーシングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・創薬におけるアウトソーシングの企業別販売動向、市場シェア、市場集中度、競争動向 ・創薬におけるアウトソーシングの世界市場規模 ・創薬におけるアウトソーシングの北米市場分析（アメリカ、カナダ、メキシコ等） ・創薬におけるアウトソーシングのアメリカ市場規模推移 ・創薬におけるアウトソーシングのカナダ市場規模推移 ・創薬におけるアウトソーシングのメキシコ市場規模推移 ・創薬におけるアウトソーシングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets. Scope of the Report: The global Outsourcing in Drug Discovery market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing...
  • ネットワークアウトソーシングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102045 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、ネットワークアウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、エンドツーエンドサービス、オンデマンドサービス等、用途別セグメントは、メディア＆エンターテイメント、製造、IT＆テレコミュニケーション、ヘルスケア＆ライフサイエンス、政府、エネルギー＆パワー、防衛、銀行、金融サービス＆保険等に区分しました。ネットワークアウトソーシングの世界市場概観、企業動向、企業別ネットワークアウトソーシングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ネットワークアウトソーシングの市場概観 ・ネットワークアウトソーシングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ネットワークアウトソーシングの企業別販売動向、市場シェア、市場集中度、競争動向 ・ネットワークアウトソーシングの世界市場規模 ・ネットワークアウトソーシングの北米市場分析（アメリカ、カナダ、メキシコ等） ・ネットワークアウトソーシングのアメリカ市場規模推移 ・ネットワークアウトソーシングのカナダ市場規模推移 ・ネットワークアウトソーシングのメキシコ市場規模推移 ・ネットワークアウトソーシングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Network outsourcing refers to migrating parts of a network to third-party company services in order to effectively shift the burden of administration and operation away from an enterprise. Scope of the Report: The global Network Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an...
  • スニチニブ薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101824 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、スニチニブ薬の世界市場について調べ、まとめました。種類別セグメントは、12.5 mgカプセル、25 mgカプセル、37.5 mgカプセル、50 mgカプセル等、用途別セグメントは、腎臓がん、GIST、pNET等に区分しました。スニチニブ薬の世界市場概観、企業動向、企業別スニチニブ薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・スニチニブ薬の市場概観 ・スニチニブ薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・スニチニブ薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・スニチニブ薬の世界市場規模 ・スニチニブ薬の北米市場分析（アメリカ、カナダ、メキシコ等）...Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. Scope of the Report: The global Sunitinib Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will...
  • アンブリセンタン薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101828 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、アンブリセンタン薬の世界市場について調べ、まとめました。種類別セグメントは、5mg錠、10mg錠等、用途別セグメントは、病院、ドラッグストア等に区分しました。アンブリセンタン薬の世界市場概観、企業動向、企業別アンブリセンタン薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アンブリセンタン薬の市場概観 ・アンブリセンタン薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アンブリセンタン薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・アンブリセンタン薬の世界市場規模 ・アンブリセンタン薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・アンブリセンタン薬のアメリカ市場規模推移 ・アンブリセンタン薬のカナダ市場規模推移 ・アンブリセンタン薬のメキシコ市場規模推移 ・アンブリセンタン薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an...
  • デシタビン薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101820 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、デシタビン薬の世界市場について調べ、まとめました。種類別セグメントは、ダコゲン、ジェネリック等、用途別セグメントは、病院、薬局等に区分しました。デシタビン薬の世界市場概観、企業動向、企業別デシタビン薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・デシタビン薬の市場概観 ・デシタビン薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・デシタビン薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・デシタビン薬の世界市場規模 ・デシタビン薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・デシタビン薬のアメリカ市場規模推移 ・デシタビン薬のカナダ市場規模推移 ・デシタビン薬のメキシコ市場規模推移 ・デシタビン薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Scope of the Report: The global Decitabine Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia...
  • シクロベンザプリン薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101834 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、シクロベンザプリン薬の世界市場について調べ、まとめました。種類別セグメントは、タブレット、カプセル等、用途別セグメントは、病院、薬局等に区分しました。シクロベンザプリン薬の世界市場概観、企業動向、企業別シクロベンザプリン薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・シクロベンザプリン薬の市場概観 ・シクロベンザプリン薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・シクロベンザプリン薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・シクロベンザプリン薬の世界市場規模 ・シクロベンザプリン薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・シクロベンザプリン薬のアメリカ市場規模推移 ・シクロベンザプリン薬のカナダ市場規模推移 ・シクロベンザプリン薬のメキシコ市場規模推移 ・シクロベンザプリン薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax. Scope of the Report: The global Cyclobenzaprine Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market...
  • チゲサイクリン薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101812 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、チゲサイクリン薬の世界市場について調べ、まとめました。種類別セグメントは、タイガシル、ジェネリック等、用途別セグメントは、病院、薬局等に区分しました。チゲサイクリン薬の世界市場概観、企業動向、企業別チゲサイクリン薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・チゲサイクリン薬の市場概観 ・チゲサイクリン薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・チゲサイクリン薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・チゲサイクリン薬の世界市場規模 ・チゲサイクリン薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・チゲサイクリン薬のアメリカ市場規模推移 ・チゲサイクリン薬のカナダ市場規模推移 ・チゲサイクリン薬のメキシコ市場規模推移 ・チゲサイクリン薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Tigecycline is an antibiotic for a number of bacterial infections. It is a glycylcycline administered intravenously. It was developed in response to the growing rate of antibiotic resistant bacteria such as Staphylococcus aureus, Acinetobacter baumannii, and E. coli. Scope of the Report: The global Tigecycline Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions....

    • ◆H&Iグローバルリサーチのお客様（例）◆